Sitemap - 2008 - The California Stem Cell Report
CIRM Begins Application Triage Experiment
Attention Scientists: CIRM Proposes Triage on Research Plans
Stem Cell Science Group Seeks $400,000 From CIRM
CIRM Clarifies Its Financial Status: Grant Money Could Run Out by June
Layoffs Loom at California State Agencies, Not Likely at CIRM
CIRM Responds to Financial Disparity Questions
Handouts vs. Cutbacks: Strange Financial Tales from the Golden State
'Armageddon' and Klein's Salary
UCSF Snags $25 Million Stem Cell Donation
How Would California Stem Cell Backers Do It Differently?
CIRM Directors To Define Vice Chair Job and Executive Evaluation Process
CIRM Panel to Consider Hoover Questions
Business Snags $5.3 Million from CIRM
Klein's Salary: News Coverage is Modest
CIRM Identifies Winners of Tools and Tech Grants
CIRM Issues Statements of Praise for Klein
CIRM Board Approves $150,000 Salary for Chairman Klein
$20 Million Handed Out by CIRM and First Ever Successful Conflict Appeal
California Governor Nominates Roth as CIRM Vice Chair
Torres Says He Needs Salary From CIRM
$1.3 Million Price Tag on CIRM Chair and Vice Chair Compensation
State Democratic Party Chief Nominated as CIRM Vice Chair
Once rejected $1.7 million grant is resurrected
Klein Says He Can't Afford to Work for Free
Gov. Schwarzenegger Concerned about $500,000 salary for CIRM Chief
Fast-Tracking CIRM Cash for Business
CIRM's Klein Deserves a Salary
CIRM Posts Timely Info on Research Standards Meeting
Closer Ties to Industry Promised in Revised CIRM Strategic Plan
CIRM Directors Meet Next Week: $210 Million Proposal on Table
A Salary for Klein? Half-Million Likely
Differing Views on the Future of the Stem Cell Industry
An Unseemly Bid for Federal Help
CIRM Turning to 'Dramatic' Increases in Therapeutic Research
Klein: Federal Backing Could Lead to $1 Billion CIRM Loan Effort
WSJ: No Magic Stem Cell Funding Cure From Feds
The Bee Assails the CIRM 'Club'
Minimal Coverage of Hoover-CIRM Inquiry
CIRM No-Pay Egg Rules: A 'Stem Cell Debacle'?
Klein Lobbying Group Employee Organizing pro-CIRM Turnout for Hoover Inquiry
$500 Million Biotech Loan Program Comes Up Next Week
Another Weekend CIRM Directors' Meeting on Personnel Issues
Stem Cell Snippets: Eggs to IP
Monday Deadline for Canadians on CIRM's Big Disease Team Round
Canadian-California Researchers to Compete for Golden State Cash
Little Hoover Commission Opens CIRM Probe Next Week
CIRM Says No Prompting on Penhoet Announcement
Economic Woes: California, the Stem Cell Biz and CIRM
Fresh Comment and Link to CIRM Penhoet Release
Penhoet Resigns as Vice Chairman of CIRM
Changes on CIRM Board? Penhoet, Nova Say No
2009 CGS Forecast: Petri Dishes -- Not Stem Cell Therapies
Waiting For Barack: Don't Hold Your Breath on Stem Cell Cash
Potholes in Freeways vs. Therapies in the Clinic
Conflicts of Interest, CIRM and Transparency
Sunday Afternoon with CIRM: A Personnel Matter
Rare Teleconference Session of CIRM Directors on Monday
'No Job Too Big, No Job Too Small'
UC Irvine Breaks Ground on Stem Cell Lab
UK, CIRM Ink Collaboration Agreement
CIRM IP Hearing Set for Oct. 29
Tracking the Little Hoover Commission and CIRM
CIRM and the Cause of Philanthropy
Biotech Courtier, the People's Will and 'Money Talks'
CIRM Seeking Solution to Director Absenteeism
Science and Construction Dominate CIRM Newspaper Series
CIRM Denies It Was Prompted to Release Economic Study
Coming Next Spring: A $350,000 Paean to CIRM's Value
Economists Say "Too Early" to See Significant, Quantifiable CIRM Results
Finessing the CIRM Directors' Attendance Issue
Ballot Blowback: The Klein Quorum Petard
Predictive Toxicology and CIRM's Priorities
CIRM Grantees Get More Than Cash
UC Davis Moves Ahead on $62 Million Stem Cell Lab
San Diego's Sanford Center to Seek 16 Disease Team Grants
California Efficiency Panel To Scrutinize CIRM
CIRM Directors Approve Biotech Loan Policy
Klein and Sheehy Tangle Over Lucrative CIRM Contract with Former CIRM Director
More Info Emerges on CIRM Biotech Loan Effort
Big Bucks Giveaways and CIRM Integrity
CIRM Spending Plans, More Details on Biotech Loans and Delegated Underwriting,
CIRM Grant Review: Questions About Fairness, Conflicts and Accuracy
Text of Responses From CIRM Applicants
Text of Kessler's Conflict-of-Interest Comments
A "Certain Skew" Among CIRM Reviewers
Links to CIRM Grant Review Process
Advocate Reed Says No Need for Independent Look at CIRM
Biotech Loan Proposal: Questions About Affordable Access
A Theatrical Trounson Appearance in San Francisco
Biotech Loan Plan Up Again on Saturday
Doing the Public's Business in Public
The CIRM Name Game; USC Goes First
CIRM Announces $60 Million Translational Grant Round
A Partial Case for a Deep Outside Look at CIRM
Big Money Issues Come Up Next Week at CIRM
California Lawmakers Make Stem Cell History
Fallout From Disclosure of the CIRM 18
SB1565: CIRM Hopes Now Rest with Arnold
Consumer Watchdog: Some CIRM Directors Missing Work and Should Resign
A 'Booster Rocket' For Research in the 'Big Tomato'
Stemcellbattles.com Is Offline; Webmaster Hospitalized
Changes in the California Stem Cell Report
Minimal News Coverage on CIRM Faculty Grants
The Perils of Prop. 71: CIRM's Search for a Vote
$59 Million Bonanza For California Stem Cell Researchers
A Tardy CIRM Posting on New Grant Reconsideration Policies
CIRM Should Say No to Mullin Tresspass Bill
CIRM To Define PI and Their Grant Time Commitments
CIRM Releases Biotech Loan Policy
Text of BioWorld Article on CIRM Loan Program
CIRM-Funded Researcher Firebombed; CIRM Should Beef Up Reward
Fresh Comment on CIRM's Blog Ban
Major Information Remains Missing From CIRM Directors Agenda
The WSJ Looks at CIRM and Its 'Sugar Daddy'
CIRM Blog Ban: Reaction From The Agency and Readers
New Issues Added to CIRM Directors Meeting Next Week
CIRM Contracts with Fleishman PR Firm
CIRM Providing Some Early Background Info on Directors Meeting
CIRM Bans California Stem Cell Report
Loans, Eggs, Contracts, Suppliers and $41 Million Top CIRM Agenda Next Week
The $2 Million Remcho-CIRM Connection
Links to CIRM Biotech Loan Info
Patient Advocate Reed's Relentless Effort Against SB1565
CIRM Website Improves; More Info on Where The Money Goes
The Associated Press Digs Into Eggs, Money and Stem Cell Research
CIRM Revising Rules on Pre-2006 Cell Lines
Klein Confirms Resignation, Lobbying Connections Remain
CIRM Confirms Departure of General Counsel
Bee 'Flabbergasted' by Klein's Actions
Lockyer Names Quint to CIRM Directorate
CIRM Mulls Kuehl Legislation Once Again, Supplier Proposal Also on Table
The Perils of Group-Think at CIRM
A Re-Look at Friday's Egg Meeting
San Diego Researchers Say No Shortage of Human Eggs
A Critical Look at CIRM's Stem Cell Globe-Trotting
CIRM Reviews the Business of Human Eggs
Kindling the Flame in Goleta: Thomson, Klein Part of Gaucho Show
Stem Cell Affordability Bill Marches Towards Schwarzenegger
CGS Says CIRM Legislation is 'Gentle'
Text of Buck Institute Letter on SB 1565
The Media Mustard and Meaning of Klein-Kuehl Flap
Klein Resigns as Head of Stem Cell Lobbying Group
Patient Advocate Reed Praises Kuehl, Says Sometimes People Go Too Far
Stem Cell Affordability Legislation Changed to Meet CIRM Objections
CIRM Letter Opposing Kuehl Legislation
California Stem Cell Chief Says He Was Unaware of Personal Attack on Lawmaker
Consumer Watchdog: Despite Apology, Klein Still Should Still Resign
Klein's Lobbying Group Apologizes for Blistering Attack on Kuehl
Consumer Watchdog Says Klein Should Resign Because of Personal Attack on Lawmaker
Klein's Group Says Kuehl is Ignorant or Mindless or Craven and Dumb
Klein's Lobbying Group Waging Cyberspace, Patient-Advocate Battle Against SB 1565
Text of Americans for Cures Email and Links to Its Position
CIRM Director Sheehy Proposes Changes in Grant Appeals
CIRM Responds to Cascade Complaints
French, Stemagen, Trounson and Egg Shortages
Multimillion Dollar Hooha Over CIRM Grant Reviews
Text of Reconsideration Letter From Cascade
CIRM's Grant Review Process: Complaints About Errors and Appeals
Klein's Possible Salary: Comments From CIRM
Nosing Around for Stem Cell Millions
Kuehl on Klein Salary and CIRM Legislation Prospects
Video Overview of CIRM: From Bob Klein to Stem Cell Beneficiaries
CIRM Salary Freeze: Sharing the Pain
Cascade LifeSciences Critiques CIRM Grant Review Process; Questions Raised about Fairness and Facts
Novocell First Business to Score CIRM Cash
Meager Coverage of CIRM Meeting
CIRM Hires John Robson from McGill as Vice President
More California Dough -- $23 Million -- Rolls Out the Door for Stem Cell Research
The Multi-Million Supplier Debate: CIRM's Current Definition
Consumer Watchdog: CIRM Budget Needs More Explanation
More Info Disclosed For CIRM Meeting Thursday, Friday
Klein's Lobbying Group Opposes Affordable Access Bill
Defining Which Businesses Get an Edge in CIRM Research Purchases
CIRM Directors to Give Away Millions, No Details Available
Will CIRM Directors Fulfill Prop. 71 Promises?
California's Big Biotech Loan Program Headed for Approval in August?
CIRM Directors Nix Kuehl Legislation
Half-Million Salary for Klein?
$13 Million Approved for CIRM Operations
Differences in Old, New Versions of Budget Appear Minor
CIRM Changes Budget Plan for This Afternoon's Meeting
Deep Yogurt, Biotech and the Anguish of Big Pharma
CIRM Legislation on Affordable Access Moves Forward
Stem Cell Watchdog Warns of the Lure of the World Stage
Sweeping Cancer Fight Launched by CIRM and Canada
CIRM Budget to Jump Nearly 50 Percent
Canadian Money and Gladstone/Yamanaka Research
CIRM to Dish Up Millions for New Cell Line Research
Link to IP Law & Business Story
California Stem Cell Cash – Last Resort for Business?
CIRM Directors To Take Crack at Budget and Stem Cell Legislation
CIRM Proposal to End Peer Review Requirement
CIRM Dredging Up Old Economic Controversy
Stem Cell Research, Money and State Efforts
Fresh Human Eggs and Stem Cell Economics
San Francisco Business Times Surveys CIRM
Murphy and Koch: IP and Presidential Consulting
CIRM To Update Goals; Watchdog Urges Openness
Trounson and Clues to CIRM's Scientific Interests
CIRM's Outside Lawyers Win Retroactive, 66 Percent Pay Hike
Cost Overruns and Candor from CIRM
Consumer Watchdog: No Way to Run $6 Billion Enterprise
CIRM Lagging on Budget Preparation
A Brief Look at CIRM's Outside Contracts
The Murky World of $2 Million in CIRM Spending
Time to Sign Up for CIRM E-alerts
CIRM Improves Web Site, Moves to Strengthen Communications
Chiang SB 1565 Text: Support for Stricter Oversight
CIRM Lab Grants: UC Santa Cruz on Hold
CIRM Conflict Legislation Wins Support From Key State Official
Cashing in on California: Opportunities for Non-State Businesses
Ballyhoo, Economics and California Stem Cells
CIRM Affordable Access Bill Easily Clears Senate
The Harsher Reality of the FDA Hold on Geron
Affordable Access to CIRM Therapies: A Patient Advocate's Position
Complete Okarma Statement on FDA Hold
Media Play: Harvesting Organs vs. Building Stem Cell Labs
Half-Billion-Dollar Biotech Loan Proposal Moves to Finance Committee
New CIRM Audit and Foxes and Chickens
CIRM To Invest $66 Million in Intellectual Capital
Media Coverage, Lab Needs and a Proposal for a New CIRM Mantra
Consumer Watchdog Rethinks Stand on Klein's Private Contact with Grant Applicants
CIRM Conflicts: Comments from the Cerberus
Pravda to Marin: A Look at Media Coverage of CIRM's Stem Cell Grants
Beating the $1.1 Billion Stem Cell PR Drum
NY Times, San Diego UT and More on Golden State's Stem Cell Labs
New Stem Cell Labs for California: The $1.1 Billion CIRM Achievement
Media Start to Roll on CIRM Lab Grants
Time for a Party at CIRM Central
Response from Grant Applicants on Klein Contact
CIRM Agenda Still Short of Info
Klein, Zeal and CIRM's No-Contact Rule
$800 Million in New Stem Cell Labs: Haggling Over 10 Percent
California Supplier? A Minor Question Involving Stem Cell Millions
Stem Cell Snippets: Surfing the Big Wave to Practicing PR
Sunshine and $66 Million in Stem Cell Training Grants
More Details Being Posted for CIRM Meeting Next Week
Niche Comments on CIRM Conflicts
CIRM's Biotech Loan Terms and Policy To Be Aired
Trounson Speaks Tonight in San Francisco
'Nature' Assesses CIRM, Warns of Conflicts of Interest
CIRM Unveils More Details on Biotech Loan Program
More Than $262 Million On CIRM Table Next Week
Were Some Scientists' Concerns about CIRM's Claims Worthy of Note?
Growing an Arm, a Leg and an Ear
Klein's Private Group Plans Expanded National Stem Cell Push
San Diego UT: Down with Gliders, Up with ESC
Chippewa to San Francisco: The $758 Million Stem Cell Media Challenge
Stem Cell Watchdog Begins Third Year
Flamm Wins Latest Round Against Korean Stem Cell Researcher
San Diego Consortium's Stem Cell Lab Plans and How They Came About
Klein Group Says It Does Not Lobby
CIRM Charged with Political Manipulation
CIRM Exaggerates Role in San Diego Clinical Trials Research, Scientist Says
Learning How to Tell the Stem Cell Story
FDA Worries About Stem Cell Trials
Money Up Front for CIRM Lab Dough?
CIRM Executive Salaries Take a Hit
Millions Cut from CIRM Lab Grant Requests, Millions More Approved
CIRM Bill Moves on in California Legislature
CIRM Seeking Egg Donation Comments
'Doing It Right,' Cerberus Simpson Says
Bravo on Timely Posting of Lab Grant Documents
CIRM Seeking IP Lawyer and Presidential Consultant
Rabble, International Meetings and CIRM
CIRM Releases Cost on International Stem Cell Forum
Tribulation for Love and Harrison
CIRM Legislation Hearing Scheduled for Early April
An Egg Shortage: Is More Cash the Answer?
Snippets From the CIRM Egg Debate
CIRM Cerberus Has New 'Kennel'
Pricewaterhouse Report on Biotech Loans Available Online
Biotech Loan Program Eyes Matching Funds
Strong Interest in $41 Million CIRM Faculty Award Program
California's Huge Lab Construction Program Set for Public Airing
WARF Scores in Patent Struggle
Legal Action in Multimillion Dollar CIRM HQ Promises
CIRM Salary Ranges Top Those at NIH
CIRM Salaries Approved Along with Action on 'California Suppliers'
Emory Scientist Named to Key Post at California Stem Cell Agency
Biopolitical Times: CIRM Eyeing Ways to Pay Women for Eggs
The Bee Calls for Tougher Legislation on CIRM
Biotech Loan Plan Now Available to Public
Part Two of Lab Grant Applications Now Available
The Primrose Path of Stem Cell Research in California
Dissecting the Legislative Strategy Behind the Latest California Stem Cell Bill
Background Documents Now Available for CIRM Meeting, More to Come
Wright's Departure From CIRM Illustrates Agency's Voting Practices
Kurt Cobain, CIRM and Green Footprints
CIRM's Fifty Percent Pay Range Hikes Back Again
Wired Piece on CIRM Lab Program
Light Coverage of CIRM Lab Leverage
AP Story on WARF Patent Matter
Stem Cell Patent Fight Enters Another Round
California Set for $758 Million Stem Cell Lab Construction Program
'Mystery' Documents Now Available on CIRM Research Standards
Fresh Comment: CIRM's Mystery Meeting Remains a Mystery
Trounson on 'Impressive Research' Backed by CIRM
CIRM Ill-served by Withholding Routine Information
A Look Behind the Cyberspace Curtain
CIRM Conflict Problems Behind Latest Stem Cell Bill
Lawmakers Target California Stem Cell Agency
CIRM's 50 Percent Pay Range Hike Hits Roadblock
Biotech Loan Taskforce Votes To Hire PriceWaterhouseCoopers
Negative Reaction to 'Big Bucks' at California Stem Cell Agency
CIRM Alleges Misrepresentation of Salary Proposal
CIRM Proposes 50 Percent Pay Range Hikes; Watchdog Says They are Unjustified
CIRM's Latest on Navigating the Financial 'Valley of Death'
Day-long CIRM Meeting: No Topic Disclosed
Stem Cell Mischief and 'Research Sites'
PR Laundering Update: Subcontracting Unusual, Says Industry Publication
California Governor Says Invitrogen and Biotech Leading The Way
Some CIRM Grant Applicants Disqualified
Secret PR for Legal Proceedings? A Comment
More Than 100 Requests for CIRM Millions
Bean Town Perspective: California Still Waiting for Stem Cell Results
Margolis: Beware the Embryonic Cheerleaders
Tackling Stem Cell Collaboration
Arnold Involved in CIRM Legal/PR Strategy?
Rubenstein Responds to 'Laundering' Charges
"Laundering" PR Advice at $3 Billion California State Agency
Klein's Role in Raising Matching Lab Grant Funds
Biotech Loans: Industry Reaction, 30-40 Percent Failures, IP Qualms
More on Wednesday's session on Stem Cell Research
Exploring Research Roadblocks and Cooperation
'California Has Changed Everything'
Snippets: Stem Cell Lending to Pizzo Profile
Investors to Bush: We Like hESC
CIRM To Bush: Harmful and Wrong
Coverage of the Cloning of the Cells of Sam Wood
Meager News Coverage of Stem Cell Lab Grants
Childrens Hospital Loses Bid for Lab Grant; 12 Survive
Details Emerging on Possible Shape of Big Biotech Loan Program
Rejected Grant Applicant Steps Up its Bid for Approval
Childrens Hospital's Second Letter
Seeking Summaries: The Hunt for How $263 Million Will Be Spent
Zipped Lips and CIRM's $263 Million
FTCR: Rejected Lab Grant Applicants Should Appeal in Public
Time for Business to Weigh in on CIRM Biotech Loan Plan
Stem Cell PR, John Scully and Stanford
FTCR: Is CIRM 'Missing the Laboratory for the Test Tubes?'
Monkey Business, BioTime and the Search for Science
FTCR on Childrens Hospital Appeal: Fairness v. Secrecy
Rejected CIRM Grant Applicant Seeks Reversal of Action
Text of Lab Grant Appeal Letter
Limos, Red Flags and Perception
CIRM's Perspective on Staffing in Klein's Office
Two San Diego Area Firms Seeking Cash From CIRM
The Cerberus and The Scientist
CIRM Directors Meet to Mull More Faculty Awards, Mega Millions for Labs
CIRM's Klein Beefs Up His Staff
Stem Cell Snippets: Toes, Public Support and Looking Forward